Mildronate represents an anti-ischemic drug within the hydrazine class, primarily utilized for the treatment of cardiac conditions such as angina pectoris, ischemic cardiomyopathy, and chronic heart failure.… Read more
Mildronate represents an anti-ischemic drug within the hydrazine class, primarily utilized for the treatment of cardiac conditions such as angina pectoris, ischemic cardiomyopathy, and chronic heart failure. This category offers a comprehensive range of reference standards, including the active pharmaceutical ingredient, its pharmacopeial and non-pharmacopeial impurities, specific metabolites like N-nitroso mildronate, and stable isotope-labelled compounds. Pharmaceutical laboratories rely on these high-quality materials for precise impurity profiling, method validation, and rigorous quality control during the manufacturing process. By utilizing consistent reference materials, researchers can ensure accurate quantification and identification of drug-related degradants and by-products. The inclusion of stable isotope-labelled standards further supports internal standard calibration in advanced analytical techniques like liquid chromatography-mass spectrometry, ensuring reliable results across complex pharmaceutical research and development applications.